Zurex Pharma Raises $9M
Zurex Pharma, a pharma and medical technology company with a novel antimicrobial technology platform, raised $9 million in advance of a pending new drug application (NDA) submission, the company announced…
Category Archives: Biotech
Propeller Gets Funding from McKesson
Along with the $20 million funding round announced last week, Propeller Health announced recently that McKesson Ventures also has made an investment in the company. According to a release, the undisclosed…
Cellular Dynamics, UC-Irvine Form Agreement
FUJIFILM Cellular Dynamics, Inc. (FCDI) and the University of California – Irvine have entered into an exclusive patent license agreement that will enable FCDI to differentiate pluripotent stem cells into…
Exact Sciences Reports on New Blood Test
Exact Sciences, along with researchers at the Mayo Clinic, announced today that they have developed a blood test that correctly identified 95 percent of the cases of a common form…
Propeller Health Raises $20M
Propeller Health announced today that it has raised $20 million to support its investment in its pipeline of digital therapeutics and additional connected devices for the treatment of chronic respiratory disease….
BioForward Adds Eight to Board
Eight new members were voted onto the BioForward board of directors, the organization announced today. Serving a 2018-20 term from Madison are University of Wisconsin School of Medicine and Public Health…
FluGen Begins M2SR Clinical Trial
FluGen announced today it has dosed its first patients in a clinical trial of a novel investigational influenza vaccine called M2SR against multi-season mismatched strains, in Belgium. “If successful, the results from…
Cellectar Granted RPDD by FDA
Cellectar Biosciences announced today that the U.S. Food and Drug Administration has granted rare pediatric disease designation (RPDD) to its phospholipid drug conjugate, CLR 131, for the treatment of neuroblastoma….
Study Shows Propeller Reduces Asthma Burden
Propeller Health’s respiratory management system was used to reduce asthma burden in a recent study published in the healthcare journal Health Affairs, the company announced recently. According to a release,…
Cellectar Biosciences Nets Patent
The U.S. Patent and Trademark Office has awarded Cellectar Biosciences a patent (No. P150207US03) that covers a method of use for CLR 131 in multiple myeloma, the company announced today….
